BioWorld Asia

June 18, 2008

View Archived Issues

Genfit, GenOway Getting Public Support for Diabetes Program

Ion Channel Could Pose New Target for Antimalarial Drugs

Report: Lack of Adequate Capital Puts Biotech Innovation at Risk

Creabilis Names UK Industry Vet CEO; Prepares for Phase II

Acacia Advances to Clinic with Lead Oncology Drug, APD 405

Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia

SiRNAsense Picks Polyplus's in Vivo Delivery Platform

AmVac, Icon Genetics Team on Plant-Based Influenza Vaccine

Swiss vaccine developer AmVac AG is teaming up with Bayer AG subsidiary Icon Genetics GmbH to develop a plant-based production system for making an adjuvanted influenza vaccine. (BioWorld International) Read More

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...